Jayakumar, A <br/><br/>
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.  [electronic resource] 

 -  Tuberculosis (Edinburgh, Scotland)  Jul 2015 
 - 415-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1873-281X 
<br/><br/><label>Standard No.: </label>10.1016/j.tube.2015.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Antitubercular Agents--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Cytokines--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Host-Pathogen Interactions<br/>Humans<br/>Logistic Models<br/>Male<br/>Multivariate Analysis<br/>Mycobacterium tuberculosis--drug effects<br/>Predictive Value of Tests<br/>Receptors, Cytokine--blood<br/>Receptors, Tumor Necrosis Factor, Type I--blood<br/>Time Factors<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--blood<br/>Uganda<br/>Young Adult